|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liu R, Li J, Xie K, Zhang T, Lei Y, Chen
Y, Zhang L, Huang K, Wang K, Wu H, et al: FGFR4 promotes
stroma-induced epithelial-to-mesenchymal transition in colorectal
cancer. Cancer Res. 73:5926–5935. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ting L, Jun H and Junjie C: RAD18 lives a
double life: Its implication in DNA double-strand break repair. DNA
Repair (Amst). 9:1241–1248. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wu B, Wang H, Zhang L, Sun C, Li H, Jiang
C and Liu X: High expression of RAD18 in glioma induces
radiotherapy resistance via down-regulating P53 expression. Biomed
Pharmacother. 112:1085552019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang Y, Gao Y, Zlatanou A, Tateishi S,
Yurchenko V, Rogozin IB and Vaziri C: Diverse roles of RAD18 and
Y-family DNA polymerases in tumorigenesis. Cell Cycle. 17:833–843.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li M, Larsen L and Hedglin M: Rad6/Rad18
competes with DNA polymerases η and δ for PCNA encircling DNA.
Biochemistry. 59:407–416. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wong RP, Aguissa-Tourè AH, Wani AA,
Khosravi S, Martinka M, Martinka M and Li G: Elevated expression of
Rad18 regulates melanoma cell proliferation. Pigment Cell Melanoma
Res. 25:213–218. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xie C, Lu D, Xu M, Qu Z, Zhang W and Wang
H: Knockdown of RAD18 inhibits glioblastoma development. J Cell
Physiol. 234:21100–21112. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lou P, Zou S, Shang Z, He C, Gao A, Hou S
and Zhou J: RAD18 contributes to the migration and invasion of
human cervical cancer cells via the interleukin-1β pathway. Mol Med
Rep. 20:3415–3423. 2019.PubMed/NCBI
|
|
10
|
Zou S, Yang J, Guo J, Su Y, He C, Wu J, Yu
L, Ding WQ and Zhou J: RAD18 promotes the migration and invasion of
esophageal squamous cell cancer via the JNK-MMPs pathway. Cancer
Lett. 417:65–74. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yan X, Chen J, Meng Y, He C, Zou S, Li P,
Chen M, Wu J, Ding WQ and Zhou J: RAD18 may function as a predictor
of response to preoperative concurrent chemoradiotherapy in
patients with locally advanced rectal cancer through
caspase-9-caspase-3-dependent apoptotic pathway. Cancer Med.
8:3094–3104. 2019.PubMed/NCBI
|
|
12
|
Loboda A, Nebozhyn MV, Watters JW, Buser
CA, Shaw PM, Huang PS, Van't Veer L, Tollenaar RA, Jackson DB,
Agrawal D, et al: EMT is the dominant program in human colon
cancer. BMC Med Genomics. 4:92011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lu J, Li D, Zeng Y, Wang H, Feng W, Qi S
and Yu L: IDH1 mutation promotes proliferation and migration of
glioma cells via EMT induction. J BUON. 24:2458–2464.
2019.PubMed/NCBI
|
|
14
|
Wu K, Li L, Li L and Wang D: Long
non-coding RNA HAL suppresses the migration and invasion of serous
ovarian cancer by inhibiting EMT signaling pathway. Biosci Rep.
40(pii): BSR201944962020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Schulz A, Gorodetska I, Behrendt R,
Fuessel S, Erdmann K, Foerster S, Datta K, Mayr T, Dubrovska A and
Muders MH: Linking NRP2 With EMT and Chemoradioresistance in
bladder cancer. Front Oncol. 9:14612020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhou J, Zhang S, Xie L, Liu P, Xie F, Wu
J, Cao J and Ding WQ: Overexpression of DNA polymerase iota (Polι)
in esophageal squamous cell carcinoma. Cancer Sci. 103:1574–1579.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zou S, Shang ZF, Liu B, Zhang S, Wu J,
Huang M, Ding WQ and Zhou J: DNA polymerase iota (Pol ι) promotes
invasion and metastasis of esophageal squamous cell carcinoma.
Oncotarget. 7:32274–32285. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hur K, Toiyama Y, Takahashi M, Balaguer F,
Nagasaka T, Koike J, Hemmi H, Koi M, Boland CR and Goel A:
MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT)
in human colorectal cancer metastasis. Gut. 62:1315–1326. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kho DH, Bae JA, Lee JH, Cho HJ, Cho SH,
Lee JH, Seo YW, Ahn KY, Chung IJ and Kim KK: KITENIN recruits
Dishevelled/PKC delta to form a functional complex and controls the
migration and invasiveness of colorectal cancer cells. Gut.
58:509–519. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Williams CS, Zhang B, Smith JJ, Jayagopal
A, Barrett CW, Pino C, Russ P, Presley SH, Peng D, Rosenblatt DO,
et al: BVES regulates EMT in human corneal and colon cancer cells
and is silenced via promoter methylation in human colorectal
carcinoma. J Clin Invest. 121:4056–4069. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jackstadt R, Röh S, Neumann J, Jung P,
Hoffmann R, Horst D, Berens C, Bornkamm GW, Kirchner T, Menssen A
and Hermeking H: AP4 is a mediator of epithelial-mesenchymal
transition and metastasis in colorectal cancer. J Exp Med.
210:1331–1350. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Libanje F, Raingeaud J, Luan R, Thomas Z,
Zajac O, Veiga J, Marisa L, Adam J, Boige V, Malka D, et al: ROCK2
inhibition triggers the collective invasion of colorectal
adenocarcinomas. EMBO J. 38:e992992019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yin Y, Zhang B, Wang W, Fei B, Quan C,
Zhang J, Song M, Bian Z, Wang Q, Ni S, et al: miR-204-5p inhibits
proliferation and invasion and enhances chemotherapeutic
sensitivity of colorectal cancer cells by downregulating RAB22A.
Clin Cancer Res. 20:6187–6199. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Stiegelbauer V, Vychytilova-Faltejskova P,
Karbiener M, Pehserl AM, Reicher A, Resel M, Heitzer E, Ivan C
Bullock M, Ling H, et al: miR-196b-5p regulates colorectal cancer
cell migration and metastases through interaction with HOXB7 and
GALNT5. Clin Cancer Res. 23:5255–5266. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kahlert C, Lahes S, Radhakrishnan P, Dutta
S, Mogler C, Herpel E, Brand K, Steinert G, Schneider M,
Mollenhauer M, et al: Overexpression of ZEB2 at the invasion front
of colorectal cancer is an independent prognostic marker and
regulates tumor invasion in vitro. Clin Cancer Res. 17:7654–7663.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang AD, Fan F, Camp ER, van Buren G, Liu
W, Somcio R, Gray MJ, Cheng H, Hoff PM and Ellis LM: Chronic
oxaliplatin resistance induces epithelial-to-mesenchymal transition
in colorectal cancer cell lines. Clin Cancer Res. 12:4147–4153.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kumara HM, Feingold D, Kalady M, Dujovny
N, Senagore A, Hyman N, Cekic V and Whelan RL: Colorectal resection
is associated with persistent proangiogenic plasma protein changes:
Postoperative plasma stimulates in vitro endothelial cell growth,
migration, and invasion. Ann Surg. 249:973–977. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Belov L, Zhou J and Christopherson RI:
Cell surface markers in colorectal cancer prognosis. Int J Mol Sci.
12:78–113. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Castagnola P and Giaretti W: Mutant KRAS,
chromosomal instability and prognosis in colorectal cancer. Biochim
Biophys Acta. 1756:115–125. 2005.PubMed/NCBI
|
|
32
|
Tokarz P and Blasiak J: The role of
microRNA in metastatic colorectal cancer and its significance in
cancer prognosis and treatment. Acta Biochim Pol. 59:467–674. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Rokavec M, Öner MG, Li H, Jackstadt R,
Jiang L, Lodygin D, Kaller M, Horst D, Ziegler PK, Schwitalla S, et
al: IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated
colorectal cancer invasion and metastasis. J Clin Invest.
124:1853–1867. 2014. View
Article : Google Scholar : PubMed/NCBI
|
